<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137876">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01917981</url>
  </required_header>
  <id_info>
    <org_study_id>HASTE-1</org_study_id>
    <nct_id>NCT01917981</nct_id>
  </id_info>
  <brief_title>Testing the Accuracy of a Personal Heart Rhythm Monitor to Detect Prolonged Paroxysmal Atrial Fibrillation</brief_title>
  <official_title>Testing the Accuracy of an Intermittent Personal Heart Rhythm Monitor (PHRM) to Detect Prolonged Paroxysmal Atrial Fibrillation (PAF) Against Implantable Devices.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Surrey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Royal Surrey County Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ashford and St. Peter's Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Surrey</source>
  <oversight_info>
    <authority>United Kingdom: National Health Service</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine the sensitivity and specificity of a Personal Heart Rhythm
      Monitor in the detection of prolonged paroxysmal atrial fibrillation (defined as lasting
      more than 12 hours) against pre-existing implantable devices, seen to be the 'gold-standard'
      for arrhythmia detection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Investigators aim to recruit 30 volunteers with implantable devices (either conventional
      pacemakers, with an atrial lead or implantable loop recorders, devices inserted under the
      skin to monitor the heart rhythm). They will be attending for their routine pacemaker checks
      in a number of clinics in Surrey.

      Potential participants will have documented prolonged paroxysmal atrial fibrillation (PAF,
      an intermittent irregular heart rhythm which is known to predispose to stroke),  lasting at
      least 12 hours, identified in the last month prior to the pacemaker check.

      Willing patients will then be issued with a PHRM (Personal Heart Rhythm Monitor) device to
      make heart rhythm recordings for 3 months.  They will do this twice-daily for 30 seconds for
      this period.  At the end of the 3 month period patients will undergo a final pacing device
      check.  Identification of prolonged PAF using the PHRM device will be compared to the
      implantable device.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>The sensitivity and specificity of detection of prolonged paroxysmal atrial fibrillation (PAF) using a Personal Heart Rhythm Monitor (PHRM), compared to an implantable device.</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured (%) as the number of identified episodes of prolonged PAF using the PHRM compared to the gold standard implantable device in all patients over the 3 month period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The sensitivity and specificity of detection of all episodes of PAF using a PHRM, compared to an implantable device.</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured (%) as the number of identified episodes of all episodes of PAF (lasting at least 30 seconds) using the PHRM compared to the gold standard implantable device in all patients over the 3 month period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant compliance with twice-daily recordings with the PHRM for a three month period.</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured as actual number of recordings made out of 180 requested recordings and expressed as a percentage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The concordance of the interpretation of PHRM recordings by a Research Nurse and blinded Cardiologist.</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The agreement in the diagnosis of normal sinus rhythm and PAF using PHRM recordings between a Research Nurse and Cardiologist expressed as a percentage.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Personal Heart Rhythm Monitor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intermittent cardiac monitoring with a Personal Heart Rhythm Monitor for three months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Personal Heart Rhythm Monitor</intervention_name>
    <arm_group_label>Personal Heart Rhythm Monitor</arm_group_label>
    <other_name>Portable ECG monitor HCG-801 - OMRON Healthcare</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Prolonged AF (defined as an episode at least 12 hours duration) in the last month
             whilst attending routine pacemaker check

          -  Pacing requirement &lt; 25% during the last month

        Exclusion Criteria:

          -  Lack of capacity

          -  Inability to use the Personal Heart Rhythm Monitor due to cognitive or physical
             impairment

          -  Commencement of new anti-arrhythmic drug since last pacemaker check
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippa J Howlett, MBChB MRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Surrey and The Royal Surrey County Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippa J Howlett, MBChB BSc</last_name>
    <email>philippah@doctors.org.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Edward W Leatham, MBChB MD</last_name>
    <email>eleatham@mail.scvc.co.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Peter's Hospital</name>
      <address>
        <city>Chertsey</city>
        <state>Surrey</state>
        <zip>KT16 0PJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Riyaz Kaba, MBChB MRCP</last_name>
    </contact>
    <investigator>
      <last_name>Riyaz Kaba, MRCP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Surrey County Hospital NHS Foundation Trust</name>
      <address>
        <city>Guildford</city>
        <state>Surrey</state>
        <zip>GU2 7XX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippa J Howlett, MBChB BSc MRCP</last_name>
      <email>philippah@doctors.org.uk</email>
    </contact>
    <investigator>
      <last_name>Edward W Leatham, MBChB MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippa J Howlett, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.haste.uk.com/</url>
    <description>HASTE charity website</description>
  </link>
  <link>
    <url>http://www.hasteacademy.org/</url>
    <description>HASTE Academy website</description>
  </link>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 20, 2014</lastchanged_date>
  <firstreceived_date>July 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intermittent cardiac monitoring</keyword>
  <keyword>Implantable device</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
